Free tools, free alerts. Create a free account to get sector-matched alerts and save your searches.
Create free account →
NAFDAC is intensifying regulatory oversight through new clinical trial training requirements, blacklisting of foreign suppliers, and watchlisting of local distributors, while also expanding its pharmacist reserve corps. For Nigerian SMBs in pharmaceuticals, healthcare, and related distribution, this means stricter compliance obligations and heightened supply chain scrutiny. Businesses must verify supplier and product legitimacy and stay current with mandatory trainings to avoid disruptions.
Pharmaceuticals
Healthcare
Importation and Distribution
Clinical Research
Food and Drug Regulation
Export (Fish Farming)
NAFDAC and NHREC Announce New Dates for Mandatory Stakeholders Training on Clinical Trial Regulations in Nigeria
NAFDAC
NAFDAC and NHREC have rescheduled mandatory training on clinical trial regulations for stakeholders in Nigeria.
SMBs involved in clinical trials or research must attend the training to remain compliant; non-attendance could delay or disqualify trial approvals.
Public Notice on Blacklisting Ayrtons Saunders Ltd, UK
NAFDAC
NAFDAC has blacklisted Ayrtons Saunders Ltd, UK, and its products, warning importers, distributors, and healthcare institutions against dealing with them.
SMBs importing or distributing products from this company must immediately cease and verify their supply chains to avoid regulatory penalties and product seizures.
Public Alert No. 043/2026: NAFDAC Places Products Marketed by Mofus Nigeria Ltd on Watchlist
NAFDAC
NAFDAC has placed products marketed by Mofus Nigeria Ltd on a watchlist pending regulatory investigation.
Retailers, wholesalers, and PPMVs should suspend sales of these products and cooperate with investigations to avoid sanctions.
Inauguration Ceremony of the NAFDAC Pharmacist Reserve Group
NAFDAC
NAFDAC inaugurated a Pharmacist Reserve Group of 600 pharmacists to provide voluntary service.
This may enhance regulatory capacity and support for SMBs, potentially speeding up inspections and compliance processes.
Address by Prof. Mojisola Christianah Adeyeye at the 49th Annual International Conference of the Chemical Society of Nigeria
NAFDAC
NAFDAC DG highlighted innovations in medicinal and pharmaceutical chemistry for affordable healthcare delivery.
SMBs in pharmaceutical manufacturing and research should align with innovation trends and regulatory expectations to remain competitive.
NDLEA, NAFDAC exempted from dissolution of FG parastatals boards
NAFDAC
NAFDAC and NDLEA were exempted from the dissolution of boards of federal parastatals, ensuring continuity in leadership.
Regulatory stability for SMBs dealing with NAFDAC, as existing policies and leadership remain in place.
How to Register Your Fish Farm with NEPC Nigeria: A Complete Export Guide
Other
Guide on registering fish farms with NEPC for export purposes.
SMBs in aquaculture can leverage this guide to access export markets, but must comply with NEPC registration and export standards.
Increased regulatory scrutiny on pharmaceutical imports and distribution.
Mandatory training for clinical trial stakeholders indicates tighter oversight.
Blacklisting and watchlisting of companies signal need for robust supplier verification.
NAFDAC's capacity expansion may lead to more frequent inspections.
Export opportunities for fish farmers through NEPC registration.
1
Verify all suppliers and products against NAFDAC blacklists and watchlists.
2
Register for and attend NAFDAC/NHREC mandatory clinical trial training if applicable.
3
Suspend sales of Mofus Nigeria Ltd products until investigation concludes.
4
Ensure all pharmaceutical imports have valid NAFDAC registrations.
5
For fish farmers, initiate NEPC registration to access export markets.
6
Stay updated with NAFDAC public alerts and notices.